skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Countdown to the EU MDR Update - May 2021

Download our article pack and prepare now for upcoming challenges under the new EU MDR regulations:

  • Why new compliance measures are creating potential roadblocks to approval for manufacturers
  • Navigating the shortage of notified body resources throughout the EU
  • How the uncertain virtual audit situation is threatening MDR and IVDR certificates
  • Practical strategies for managing economic operators efficiently for long-term compliance
  • The impact of COVID-19 on compliance, regulation and the auditing process
MDR Pre-Coverage Update

Be ready with the latest coverage plus insightful commentary on the EU MDR

  • Pressures on manufacturers and suppliers caused by implementation of the new regulations
  • Can EU notified bodies handle the explosion in demand for MDR-designated services?
  • The impact of Brexit and the UK/EU trade deal on the new UK regulatory system
  • Which products will be affected by MDR regulations – and how?
  • Will companies and notified bodies be ready due to COVID-19 restrictions?
MDR Pst Coverage

Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: